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Introduction
The “developmental origins of health and 
disease” concept describes how the environ-
ment may affect intrauterine development and 
early childhood, and how it induces devel-
opmental changes bearing long-term conse-
quences for health and disease risk later in life 
(Barker 2004; Barker and Thornburg 2013). 
Factors such as parental lifestyle, diet, obesity, 
and chemical and environmental exposures 
have been shown to modulate disease risk 
(Demetriou et al. 2015; Rappaport and Smith 
2010). These factors do not simply disrupt 
development or induce disease themselves; 
they can also affect onset and progress 
of disease development. Epigenetic events, 
such as changes in DNA methylation, are 
believed to play an important role in this 
process (Jaenisch and Bird 2003) and may be 
plausible candidates through which early-life 
conditions contribute to disease susceptibility 
later in life (Jirtle and Skinner 2007).
Exposure to ambient air pollution and 
particulate matter with a diameter ≤ 2.5 μm 
(PM2.5) during pregnancy may affect fetal 
growth and development, thereby increasing 
the risk of low birth weight (Ballester et al. 
2010) and preterm birth (Rappazzo et al. 2014). 
Oxidative stress is one of the putative mecha-
nisms by which PM2.5 may disrupt biological 
pathways/systems (Rossner et al. 2007). In 
addition, it has been linked with altered DNA 
methylation levels (Franco et al. 2008; Yara 
et al. 2015; Zawia et al. 2009). In biological 
media, an excess amount of reactive oxygen 
species may interact with proteins and generate 
3-nitrotyrosine residues (3-NTp), a product of 
tyrosine nitration and a biomarker of oxidative 
stress and inflammation (Ischiropoulos 1998; 
Webster et al. 2008). Preliminary evidence 
showed higher expression of 3-NTp, based on 
immuno-histochemical staining, in high-risk 
pregnancies such as preeclampsia (Bosco et al. 
2012) and insulin-dependent diabetes (Lyall 
et al. 1998). We have shown recently that the 
concentration of 3-NTp in the placenta is 
positively linked with PM2.5 exposure during 
pregnancy (Saenen et al. 2016).
The placenta is the main interface for 
maternal–fetal exchange of nutrients and 
waste, and it responds to perturbations of 
the maternal environment through adaptive 
changes (Burton and Fowden 2015; Zeltser 
and Leibel 2011). Recently, we reported 
that PM is associated with global methyla-
tion and gene-specific mitochondrial meth-
ylation in the placenta (Janssen et al. 2013, 
2015) and with mitochondrial oxidative 
DNA damage in cord blood and maternal 
blood (Grevendonk et al. 2016) in the 
ENVIRONAGE (ENVIRonmental influence 
ON early AGEing) birth cohort.
Leptin (LEP) is a hormone that regulates 
hunger and energy homeostasis via actions 
on the hypothalamus. During pregnancy, 
placental LEP plays a functional role in 
embryo implantation, intrauterine develop-
ment, and fetal growth (Sagawa et al. 2002). 
Adverse physiological conditions during 
pregnancy such as maternal obesity and 
gestational diabetes have been associated with 
higher placental LEP methylation (Lesseur 
et al. 2014b), whereas other studies have 
found lower placental LEP methylation in 
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Background: Particulate matter with a diameter ≤ 2.5 μm (PM2.5) affects human fetal 
development during pregnancy. Oxidative stress is a putative mechanism by which PM2.5 may exert 
its effects. Leptin (LEP) is an energy-regulating hormone involved in fetal growth and development.
oBjectives: We investigated in placental tissue whether DNA methylation of the LEP promoter 
is associated with PM2.5 and whether the oxidative/nitrosative stress biomarker 3-nitrotyrosine 
(3-NTp) is involved.
Methods: LEP DNA methylation status of 361 placentas from the ENVIRONAGE birth cohort 
was assessed using bisulfite-PCR-pyrosequencing. Placental 3-NTp (n = 313) was determined with 
an ELISA assay. Daily PM2.5 exposure levels were estimated for each mother’s residence, accounting 
for residential mobility during pregnancy, using a spatiotemporal interpolation model.
results: After adjustment for a priori chosen covariates, placental LEP methylation was 1.4% 
lower (95% CI: –2.7, –0.19%) in association with an interquartile range increment (7.5 μg/m3) in 
second-trimester PM2.5 exposure and 0.43% lower (95% CI: –0.85, –0.02%) in association with a 
doubling of placental 3-NTp content.
conclusions: LEP methylation status in the placenta was negatively associated with PM2.5 
exposure during the second trimester, and with placental 3-NTp, a marker of oxidative/nitrosative 
stress. Additional research is needed to confirm our findings and to assess whether oxidative/
nitrosative stress might contribute to associations between PM2.5 and placental epigenetic events. 
Potential consequences for health during the neonatal period and later in life warrant further 
exploration.
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mothers with early-onset preeclampsia (Hogg 
et al. 2013) or impaired glucose metabo-
lism (Bouchard et al. 2010). Furthermore, 
placental LEP methylation was associ-
ated with significant differences in infant 
neurobehavior scores in boys, but there were 
no significant associations in girls (n = 223 
and 221 term births, respectively) (Lesseur 
et al. 2014a). A possible link between PM2.5 
exposure during pregnancy and placental 
LEP methylation has not been investigated so 
far. We hypothesized that gestational PM2.5 
exposure during critical periods of prenatal 
life is associated with changes in placental 
DNA methylation of LEP. We also explored 
whether the oxidative stress biomarker 3-NTp 
might be acting as a mediator of the associa-
tion between PM2.5 and LEP methylation by 
comparing the association with and without 
adjustment for 3-NTp.
Methods
Study Population
The on-going ENVIRONAGE birth cohort 
recruits mother–newborn pairs at the delivery 
ward of the East-Limburg Hospital (Genk, 
Belgium). The hospital has a catchment area of 
2,422 km2 and includes rural, suburban, and 
urban municipalities with population densi-
ties ranging from 82 to 743 inhabitants/km2 
(FOD 2016). The participation rate of eligible 
mothers (mothers able to fill out a Dutch 
language questionnaire) in the birth cohort is 
approximately 61%. The questionnaire collects 
detailed information on maternal age, prepreg-
nancy body mass index (BMI), maternal 
education and occupation, smoking status, 
alcohol consumption, place of residence, use 
of medication, parity, and ethnicity of the 
newborn (Janssen et al. 2015; Saenen et al. 
2015). The study protocol was approved by the 
ethical committees of the Hasselt University 
and the East-Limburg Hospital, and complied 
with the Helsinki Declaration (http://www.
wma.net/en/30publications/10policies/b3/). 
Written informed consent was obtained from 
all participants.
In the present study, 400 bio-banked 
placental tissue samples were randomly 
selected from 502 mother–newborn pairs 
recruited between February 2010 and May 
2013. After exclusion of samples with missing 
data of PM2.5 exposure (n = 3) or lifestyle 
characteristics (n = 4) and those not meeting 
the pyrosequencing quality control criteria 
(n = 32), statistical analyses were carried 
out for 361 subjects in the PM2.5 exposure 
models. For the 3-NTp models, we addition-
ally missed 3-NTp values for 48 mother–
newborn pairs, resulting in 313 subjects for 
statistical analysis. Characteristics of these 
groups at enrolment were similar to those of 
the entire cohort (see Table S1).
Placental Sampling
Whole placentas were stored in a –20°C freezer 
within 10 min after delivery. After thawing, 
we sampled placental tissue 1–1.5 cm below 
the chorioamniotic membrane to avoid 
membrane contamination. These biopsies 
were taken at a fixed location on the fetal site 
in the quadrant right from the main artery, 
approximately 4 cm away from the umbilical 
cord, as published previously (Janssen et al. 
2014). Each biopsy was washed and rubbed 
thoroughly in a Petri dish filled with phosphate 
buffered saline to remove blood as much as 
possible, then snap-frozen in liquid nitrogen 
and archived at –80°C until DNA methylation 
and 3-NTp measurements.
DNA Methylation Analysis
Genomic DNA was isolated from placental 
tissue samples using the QIAamp DNA mini 
kit (Qiagen Inc., Venlo, the Netherlands) 
and quantified with an ND-1000 spectro-
photometer (Isogen Life Science, De Meern, 
the Netherlands). The DNA samples had 
an average yield (SD) of 8.6 (6.4) μg with 
an A260/280 ratio of 1.91 (0.08) and an 
A260/230 ratio of 2.23 (0.35). An aliquot of 
500 ng DNA from each sample was sodium 
 bisulfite– modified with the EZ-96 DNA 
methylation gold kit in a final elution volume 
of 40 μL M-elution buffer. The procedures 
were executed according to the manufactur-
er’s instructions (Zymo Research, Irvine, CA, 
USA). DNA methylation analysis was carried 
out using highly quantitative bisulfite–PCR 
(polymerase chain reaction) pyrosequencing. 
We investigated seven CpG dinucleotide sites 
within the promoter region of LEP. These 
sites were chosen from literature (Lesseur 
et al. 2013, 2014a) and data derived from the 
hg19 (GRCh37) UCSC Genome Browser 
(http://genome.ucsc.edu/) (Kent et al. 2002; 
Rosenbloom et al. 2015), illustrating signifi-
cant transcription factor binding by ChIP 
analysis to the CpG island promoter region of 
interest. Figure S1 displays the chromosomal 
position of the LEP promoter region inves-
tigated. PCR and sequencing primers were 
designed with the Pyromark Assay Design 
software (forward primer: 5´-AGG TGT ATA 
TTG AGG GTT TAG GGT TAG-3´; biotin-
ylated reverse primer: 5´-ACA TCC CTC 
CTA ACT CAA TTT C-3´; and sequencing 
primer: 5´-GGG AGT TGG AGT TAG AAA 
TG-3´). The PCR product of the LEP region 
of interest was amplified from bisulfite-
modified DNA with the Pyromark PCR kit 
(Qiagen, Inc.). Cycling conditions started 
with an initial PCR activation at 95°C for 
15 min, followed by 45 cycles at 94°C for 
30 sec, 56°C for 30 sec, and 72°C for 30 sec, 
to end with a final extension for 10 min at 
72°C. The PCR product was sequenced with 
a Pyromark Q24 Instrument (Qiagen Inc.). 
We excluded 32 samples that did not pass 
the standard quality control implemented 
in the Pyromark Q24 Advanced software 
(Qiagen Inc.) from further analysis. The 
percentage of methylation was determined 
with the Pyromark Q24 Advanced software. 
The software used different parameters for 
quality assessment including unsuccessful 
bisulfite treatment (allowed percentage), 
peak height threshold (required peak height), 
and stringency levels (pattern/sum devia-
tion in variable positions). The efficiency of 
the bisulfite-conversion process was assessed 
using non-CpG cytosine residues within the 
sequence. Duplicates of the pyrosequencing 
runs (n = 38) were highly correlated for the 
mean of the CpG sites (r2 = 0.99) as well as 
for each CpG site separately (r2 ranging from 
0.90 to 0.99).
3-Nitrotyrosine Protein 
Measurement
Thawed placental tissue samples with a 
wet weight of approximately 10 mg were 
manually homogenized on ice in lysis buffer 
[10 mM Tris-HCl (pH 7.4), 150 mM NaCl, 
1% Triton X-100 and Protease Inhibitor 
Cocktail, Complete, mini, (Roche, Basel, 
Switzerland)] and sonicated three times in 
bursts of 10 sec. The samples were allowed to 
settle for 20 min on ice and then centrifuged 
at 16,000 × g for 20 min at 4°C. The super-
natants were aliquoted and frozen at –20°C 
until further measurements.
Total protein concentration of the 
placenta sample was determined with the 
Bio-rad protein assay according to the manu-
facturer’s instructions (Bio-rad, Nazareth, 
Belgium). The amount of 3-NTp in each 
sample was quantified with a competi-
tive ELISA (Oxiselect nitrotyrosine ELISA 
kit; Cell Biolabs, San Diego, CA, USA) and 
absorbance measurements were performed 
at 450 nm using a FLUOstar Omega 
(BMG Labtech, Offenburg, Germany). 
Concentrations of 3-NTp were determined 
using a standard curve of predetermined 
nitrated BSA (bovine serum albumin) stan-
dards. Data were normalized to the amount 
of protein present in the sample and were 
presented as nM/mg protein.
Particulate Matter Air Pollution 
Exposure
PM2.5 exposure (μg/m3) concentrations were 
modeled using a spatial temporal interpola-
tion method (kriging) (Janssen et al. 2008) 
for each mother’s residential address in 
combination with a dispersion model. The 
interpolation method uses land-cover data 
obtained from satellite images (CORINE 
land-cover data set; http://www.eea.europa.
eu/data-and-maps/data/corine-land-cover-
2006-clc2006-100-m-version-12-2009) and 
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pollution data collected from a governmental 
stationary monitoring network (http://
www.irceline.be/). Coupled with a disper-
sion model (Lefebvre et al. 2013; Maiheu 
et al. 2013) that uses emissions from point 
sources and line sources, this model chain 
provides PM2.5 values in a high-resolution 
receptor grid (average grids of 25 × 25 m). 
Overall model performance was evaluated 
by leave-one-out cross-validation including 
34 monitoring points for PM2.5. Validation 
statistics of the interpolation tool explained 
> 80% of the temporal and spatial variability 
in the Flemish Region of Belgium (Maiheu 
et al. 2013). To explore potentially critical 
exposure windows, we averaged the daily 
interpolated PM2.5 concentrations for each 
of the three pregnancy trimesters, i.e., first 
trimester (week 1–13), second trimester 
(week 14–26) and third trimester (week 27–
delivery). The date of conception was esti-
mated on the basis of the first day of the 
mother’s last menstrual period, combined 
with the first ultrasound exam. Complete 
information for the residential address during 
pregnancy was obtained by questionnaire and 
checked with hospital records. For those who 
moved during pregnancy, we calculated the 
trimester-specific exposures allowing for the 
changes in address during this period (based 
on the daily exposure levels at the different 
residential addresses).
Statistical Analyses
Statistical analyses were carried out using 
SAS software (version 9.3; SAS Institute Inc., 
Cary, NC, USA). Continuous data were 
presented as mean ± SD and categorical data 
as frequencies and percentages. The 3-NTp 
content was log10-transformed to normalize 
the distribution. To avoid multiple testing, 
we evaluated the association between the 
placental methylation status of the LEP 
promoter region of interest and gestational 
PM2.5 exposure or placental 3-nitrotyrosine 
content using mixed-effects models. In these 
models, the seven studied CpG sites were 
integrated into a single factor (individual 
CpG sites treated as repeated measures using 
an unstructured covariance structure model) 
(Janssen et al. 2015). For each trimester-
specific PM2.5 exposure model, we adjusted 
for a priori chosen covariates including as 
continuous variables maternal age, gesta-
tional age, and prepregnancy body mass 
index (BMI); and as categorical variables, 
newborn sex (boy, girl), maternal education 
(low, middle, high), smoking status (never 
smoker, former smoker, smoker), ethnicity 
of the newborn (non-European, European 
origin), and trimester-specific season (season 
at gestational exposure window: autumn, 
winter, spring, summer). Socioeconomic 
status was based upon the mothers’ education 
and coded as “low” (no diploma or primary 
school), “middle” (high school), or “high” 
(college or university degree). Smoking status 
was defined as never smoker, former smoker 
(quit smoking before pregnancy), and smoker 
(continued smoking during pregnancy). The 
ethnicity of the newborn was defined on the 
basis of the native country of the newborn’s 
grandparents and was classified “of European 
origin” when two or more grandparents were 
European. In addition, because placental 
LEP methylation was measured at birth, we 
mutually adjusted each model for the other 
gestational exposure windows to estimate 
the independent effect of each trimester of 
exposure. The results are presented for each 
gestational exposure window as an absolute 
percentage change in placental LEP methyla-
tion for a trimester-specific interquartile range 
(IQR) increment in PM2.5 (μg/m3). The 
3-NTp models were adjusted for the afore-
mentioned covariates, except for trimester-
specific season which was replaced by season 
at delivery, and the estimated effect sizes are 
presented for a doubling in placental 3-NTp 
content (nM/mg protein). p-Value < 0.05 was 
used to define statistical significance.
In a sensitivity analysis, we examined the 
associations between placental LEP methyla-
tion and PM2.5 exposure or placental 3-NTp 
content while excluding mothers with gesta-
tional diabetes, gestational hypertension, 
preeclampsia, or preterm births. Furthermore, 
additional adjustment of the main model for 
mother’s total weight gain was evaluated. We 
also examined the associations between the 
methylation at individual CpG sites and PM2.5 
exposure or placental 3-NTp using multiple 
linear regressions (see Figure S2 and Table S2). 
Finally, we included placental 3-NTp as a 
covariate in the mixed-effects model of the 
association between placental LEP methyla-
tion and trimester-specific PM2.5 to determine 
whether estimated associations changed with 
adjustment for this potential mediator.
Results
Study Population Characteristics 
and Measurements in Placenta
Demographic, lifestyle, and other characteris-
tics of the total group of 361 mother–newborn 
pairs (mean maternal age, 29.4 ± 4.7 years) 
are presented in Table 1. Pregestational 
BMI averaged 24.1 ± 4.3, and 52.4% of 
the mothers had obtained a higher educa-
tion degree. Fifty mothers (13.9%) reported 
having smoked during pregnancy, whereas 
the majority (67.3%) never smoked cigarettes. 
The newborn population, comprising 189 
boys (52.3%), had a mean gestational age 
of 39.3 weeks (range, 35–42). Most of the 
newborns were term-born infants (96.1%) 
and the majority were primiparous (51.2%) 
or secundiparous (37.7%) births. Mean birth 
weight and length were 3,426 ± 450 g and 
50.5 ± 2.1 cm respectively. The population 
characteristics of the 3-NTp group (n = 313) 
were consistent with those from the total group 
(Table 1). The 3-NTp levels averaged (range) 
3,703 (100–23,681) nM/mg protein and the 
mean (range) methylation levels of the seven 
CpG sites investigated in the placental LEP 
promoter region are shown in Table 2. The 
mean methylation level of CpG4 (61.5%) was 
substantially higher than the other six CpG 
sites (< 22.3%).
PM2.5 Exposure
The distributions of the outdoor PM2.5 levels 
for the different time windows of pregnancy 
are shown in Table 3. The average (25th–75th 
percentile) trimester-specific PM2.5 exposure 
was 15.7 (11.5–19.7) μg/m3 for the first 
trimester, 15.5 (11.4–18.9) μg/m3 for the 
Table 1. Characteristics of mother–newborn pairs.
Characteristics
Total group 
(n = 361)
3-NTp group 
(n = 313)
Mother
Age, years 29.4 ± 4.7 29.5 ± 4.6
Prepregnancy BMI (kg/m2) 24.1 ± 4.3 24.1 ± 4.5
Total weight gain (kg)a 14.8 ± 6.9 14.6 ± 7.1
Education 
Low 47 (13.0) 38 (12.1)
Middle 125 (34.6) 105 (33.6)
High 189 (52.4) 170 (54.3)
Self-reported smoking status 
Never smoker 243 (67.3) 212 (67.7)
Former smoker 68 (18.8) 59 (18.9)
Smoker 50 (13.9) 42 (13.4)
Parity
1 185 (51.2) 164 (52.4)
2 136 (37.7) 116 (36.1)
≥ 3 40 (11.1) 33 (10.5)
Pregnancy complications
Gestational diabetes 13 (3.6) 13 (4.2)
Gestational hypertension 7 (1.9) 6 (1.9)
Preeclampsia 2 (0.6) 2 (0.6)
Preterm birth 14 (3.9) 12 (3.8)
Newborn
Sex
Male 189 (52.3) 164 (52.4)
Ethnicity
European 310 (85.9) 271 (86.6)
Gestational age (weeks) 39.3 ± 1.3 39.3 ± 1.3
Born at term (≥ 37 weeks) 347 (96.1) 301 (96.2)
Season of delivery
Spring 100 (27.7) 88 (28.1)
Summer 51 (14.1) 41 (13.1)
Autumn 102 (28.3) 86 (27.5)
Winter 108 (29.9) 98 (31.3)
Apgar score after 5 min
6 1 (0.3) 0 (0)
7 6 (1.7) 6 (1.9)
8 16 (4.4) 15 (4.8)
9 102 (28.2) 86 (27.5)
10 236 (65.4) 206 (65.8)
Birth weight (g) 3,426 ± 450 3,424 ± 450
Birth length (cm)a  50.5 ± 2.1  50.5 ± 2.1
3-NTp, 3-nitrotyrosine. Continuous data are presented as 
mean ± SD; categorical variables as n (%).
aData available for 360 and 312 subjects respectively.
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second trimester, and 17.2 (12.0–21.9) μg/m3 
for the third trimester of pregnancy.
Placental LEP Promoter 
Methylation at Birth and its 
Association with PM2.5 Exposure 
or Placental 3-Nitrotyrosine
The seven CpG sites investigated in the 
placental LEP promoter region were highly 
correlated with each other (r = 0.47–0.88). 
In male neonate placentas, the LEP promoter 
methylation was higher compared to placentas 
of female neonates [1.33%; 95% confidence 
interval (CI): 0.40, 2.27%, p = 0.005 for the 
male neonate placenta vs. the female neonate 
placenta]. LEP promoter methylation was 
not associated with mother’s prepregnancy 
BMI (0.003%; 95% CI: –0.10, 0.11%; 
p = 0.96 for a 1-unit increase in BMI based 
on the adjusted mixed-effects model of LEP 
methylation and trimester-specific PM2.5) 
(see Table S2) or total weight gain (–0.042%; 
95% CI: –0.11, 0.03%; p = 0.24 for a 1-unit 
increase in total weight gain based on the 
same model, but without adjustment for pre-
pregnancy BMI) (see Table S2). We fitted a 
mixed-effects model to evaluate the association 
between the methylation levels in the LEP 
promoter region of interest (individual CpG 
sites treated as repeated measures) and PM2.5 
exposure. After adjustment for newborn sex, 
maternal age, maternal education, smoking 
status, gestational age, prepregnancy BMI, 
ethnicity, and gestational trimester-specific 
season, we estimated that overall LEP meth-
ylation in the placenta was 1.4% lower 
(95% CI: –2.7, –0.19%, p = 0.02) with an 
IQR increment in second-trimester PM2.5 
exposure (7.5 μg/m3) (Figure 1). No asso-
ciations were observed between overall 
LEP methylation and an IQR increment in 
first-trimester PM2.5 exposure (8.2 μg/m3) 
(0.49%; 95% CI: –0.97, 1.95%; p = 0.51) or 
third-trimester PM2.5 exposure (9.9 μg/m3) 
(–0.14%; 95% CI: –1.58, 1.30%, p = 0.13).
Both before (data not shown) and after 
adjustment for covariates (newborn sex, 
maternal age, maternal education, smoking 
status, gestational age, prepregnancy BMI, 
ethnicity, and season of delivery), a doubling in 
placental 3-NTp content at birth was associated 
with a significantly lower overall methylation 
level of the LEP region evaluated (–0.43%; 
95% CI: –0.85, –0.02%, p = 0.04) (Figure 1).
Sensitivity Analysis
A sensitivity analysis in which preterm births 
(n = 14 for total group; n = 12 for 3-NTp 
group), mothers with gestational diabetes/
hypertension (n = 20 for total group; n = 19 
for 3-NTp group), and mothers with 
preeclampsia (n = 2 for both groups) were 
excluded showed very little change in the 
estimated associations between the overall 
placental methylation of the LEP promoter 
region and second-trimester PM2.5 exposure 
or placental 3-NTp content (see Table S3). 
Additional adjustment of the main mixed-
effects model for mother’s total weight gain 
during pregnancy did not change statistical 
significance (see Table S3). Evaluation of 
the individual CpG sites based on multiple 
linear regression models suggested that 
associations were strongest with four of the 
seven individual CpG sites (CpG1: –1.5%; 
95% CI: –3.1, 0.10%; p = 0.06; CpG2: 
–1.4%; 95% CI: –2.8, –0.03%, p = 0.05; 
CpG3: –1.3%; 95% CI: –2.7, –0.008%, 
p = 0.05; and CpG5: –1.8%; 95% CI: 
–3.4, –0.09%, p = 0.04) (Figure 2). For 
a doubling in placental 3-NTp, the results 
of LEP methylation suggested solid associa-
tions with two individual CpG sites (CpG2: 
–0.50%; 95% CI: –0.97, –0.03%, p = 0.04 
and CpG5: –0.53%; 95% CI: –1.10, –0.05%, 
p = 0.07) (see Figure S2). Finally, adjustment 
of the main mixed-effects model for placental 
3-NTp content (n = 313) resulted in a weak-
ening of the association between placental 
LEP promoter methylation and PM2.5 
exposure of the second gestational window 
(–1.1%; 95% CI: –2.4, 0.22%; p = 0.10 vs. 
–1.33%; 95% CI: –2.63, –0.03%, p = 0.04).
Discussion
The human placenta is the anatomo- 
physiological barrier between mother and 
fetus. External factors may interfere with 
placental functions and alter signaling 
pathways, hormone production, nutrient 
and waste transfer, embryo implantation, 
and cellular growth (Myllynen et al. 2005). 
Literature suggests that epigenetic mecha-
nisms play a role in the complex interplay 
between environment and genes, and may 
predispose to disease phenotypes (Jaenisch 
and Bird 2003; Jirtle and Skinner 2007). 
In a previous study on the ENVIRONAGE 
birth cohort we showed a positive asso-
ciation between PM2.5 exposure and placental 
3-NTp (Saenen et al. 2016). The key findings 
of the present study are the significant inverse 
associations of both second-trimester PM2.5 
exposure and placental 3-NTp concentrations 
at birth with DNA methylation of the LEP 
promoter region in the placenta. Associations 
varied among the individual CpG sites.
During pregnancy, LEP is thought to play 
a functional role in embryo implantation, 
intrauterine development, and fetal growth 
(Hassink et al. 1997; Sagawa et al. 2002). It 
has been shown that umbilical cord blood 
LEP concentrations were positively correlated 
with term birth weight in a study population 
that included 70 newborns with intrauterine 
growth retardation and 62 newborns classi-
fied as having normal growth (Jaquet et al. 
1998). In the placenta, LEP is synthesized 
by trophoblasts and mostly secreted in the 
maternal blood circulation (Sagawa et al. 
2002). Studies indicated that the contribu-
tion of placental LEP secretion to circulating 
fetal leptin is minimal (Lepercq et al. 2001; 
Linnemann et al. 2001), and that fetal 
adipose tissue is most likely the main source 
of fetal LEP (Clapp and Kiess 1998; Jaquet 
et al. 1998; Lepercq et al. 2001).
Reproductive events involving leptin 
are crucial for adequate functional develop-
ment of the placenta, including regulation 
of nutrient transport, placental angiogenesis, 
trophoblast mitogenesis, and immuno-
modulation (Henson and Castracane 2000). 
When LEP binds to its receptor, it stimulates 
angiogenic factors such as the vascular endo-
thelial growth factor, thereby activating p38, 
MAPK, and Akt pathways that induce prolif-
eration, motility, and angiogenesis (Garonna 
et al. 2011). These processes are critical in 
placental development, angiogenesis in villi, 
and fetal-derived vascularization (Demir et al. 
1997). Furthermore, in situ hybridization and 
immunohistochemistry of placental tissue 
showed that placental LEP in humans is 
expressed in syncytiotrophoblast cells (facing 
maternal circulation) and villous vascular 
endothelial cells (facing fetal circulation) (Lea 
et al. 2000).
For the second-trimester exposure 
window, we found a decreased LEP methyla-
tion in placental tissue at the fetal side in asso-
ciation with an IQR increment (7.5 μg/m3) 
in PM2.5 exposure. The negative association 
with placental LEP methylation is in line 
with evidence of LEP hypomethylation in 
Table 2. Molecular measurements on placental 
tissue samples (n = 361).
Measurement Mean (range)
3-NTp (nM/mg protein)a 3,703 (100–23,681)
LEP methylation (%)
CpG1 10.0 (0.53–42.9)
CpG2 12.7 (0.66–38.0)
CpG3 8.5 (0.91–34.9)
CpG4 61.5 (33.5–88.6)
CpG5 13.6 (2.0–34.9)
CpG6 13.5 (1.1–38.2)
CpG7 22.3 (0.52–47.6)
a3-Nitrotyrosine, geometric mean (range), n = 313.
Table 3. Exposure characteristics of airborne particulate matter ≤ 2.5 (PM2.5) (n = 361).
Time windows PM2.5 (μg/m3) Mean ± SD
10th 
percentile
25th 
percentile Median
75th 
percentile
90th 
percentile IQR
Trimester 1 (1–13 weeks) 15.7 ± 5.3 10.0 11.5 13.9 19.7 24.0 8.2
Trimester 2 (14–26 weeks) 15.5 ± 4.9 10.0 11.4 14.6 18.9 22.9 7.5
Trimester 3 (27 weeks–delivery) 17.2 ± 5.8 10.1 12.0 16.9 21.9 25.6 9.9
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placenta of complicated pregnancies such as 
early-onset preeclampsia (Hogg et al. 2013) 
and impaired glucose metabolism (Bouchard 
et al. 2010), both known to adversely influ-
ence placental growth and vascularization. 
This is consistent with earlier observations of 
increased placental LEP expression reported 
in other studies of complicated pregnan-
cies (Lepercq et al. 1998; Mise et al. 1998). 
Placental LEP is believed to exert a local 
protective immunomodulating response 
(Ashworth et al. 2000). Because successful 
pregnancies are associated with downregula-
tion of proinflammatory cytokines such as 
tumor necrosis factor alpha, LEP may have 
a local protective response at the maternal–
fetal interface (Lea et al. 1997; Takahashi 
et al. 1999). In the context of this literature 
evidence, future studies should address 
the consequences of hypomethylation of 
the placental LEP status and its possible 
involvement in placental immunomodulation 
and vascularization.
In addition to the negative association 
between placental LEP promoter methylation 
and mid-gestation PM2.5 exposure, we found 
also a negative association between LEP 
promoter methylation and placental 3-NTp 
content, which was independent of maternal 
smoking and other factors. The prevalence 
of 3-NTp, based on immuno-histochemical 
staining, has been observed in two small 
studies with different high-risk pregnan-
cies, including preeclampsia and gestational 
diabetes (Bosco et al. 2012; Lyall et al. 1998). 
In these complicated pregnancies, the higher 
presence and level of 3-NTp residues in 
placental tissue may indicate vascular damage 
(Myatt and Cui 2004). An experimental study 
investigating diesel exhaust particle (DEP) 
exposure in mice suggested that in utero 
DEP promotes vascular oxidative stress as 
shown by elevated 3-NTp protein modifi-
cation (Weldy et al. 2014). The presence of 
3-NTp in placenta and its association with 
PM2.5 exposure (Saenen et al. 2016) may be 
 indicative of a PM-linked inflammation.
It is important to mention that a TATA 
box and a potential binding site for the 
C/EBP transcription factor are present in the 
studied promotor region. CpG4 is situated in 
the recognition sequence of C/EBP (Marchi 
et al. 2011). An experimental study investi-
gating methylation-dependent transcriptional 
activity of a human LEP promoter fragment 
in Lisa-2 cultured cells (a liposarcoma cell 
line) showed that methylation of the CpG4 
site (corresponding to CpG position –51 in 
Figure 6 of Melzner et al. 2002) was impor-
tant for down-regulation of promoter activity 
of LEP (Melzner et al. 2002). Demethylation 
of the CpG sites, which are proximal to the 
TATA box, was found essential for LEP 
expression in primary fibroblasts and HeLa 
cells (Marchi et al. 2011). PM2.5 air pollu-
tion was not significantly associated with 
methylation of the CpG4 site in our study. 
We observed that the individual CpG sites 
varied in average methylation, especially at 
the CpG4 site, which was substantially 
higher methylated than the other CpG 
sites. Methylation at the CpG2, 3, and 5 
sites, which flank the transcription factor 
sequence as well as the TATA box region, 
was significantly lower in association with 
an IQR increase in second-trimester PM2.5 
air pollution.
We acknowledge some study limitations. 
First, pyrosequencing assays can capture 
only a small region of 80 base pairs in the 
LEP promoter region, and it is possible that 
we missed additional methylation changes 
in the promoter region. On the other hand, 
bisulfite-PCR-pyrosequencing has the advan-
tage of being a highly standardized quanti-
tative procedure that allowed us to obtain 
accurate results (Dejeux et al. 2009; Tost and 
Figure 1. Placental LEP promoter DNA methylation 
in association with PM2.5 exposure for different 
time windows of pregnancy (n = 361) or placental 
3-nitrotyrosine (3-NTp) at birth (n = 313). Models 
were adjusted for newborn sex, maternal age, 
maternal education, maternal smoking status, 
gestational age, prepregnancy BMI, ethnicity, and 
season (i.e., gestational trimester-specific season 
in the PM2.5 exposure models and season of 
delivery in the 3-NTp model). The trimester-specific 
PM2.5 exposure models were mutually adjusted 
for the other gestational exposure windows to 
estimate the independent effect of each trimester 
of exposure. Estimates are presented as an 
absolute percentage difference in placental LEP 
promoter DNA methylation for a trimester-specific 
interquartile range increment in PM2.5 exposure 
(trimester 1: 8.2  μg/m3; trimester 2: 7.5  μg/m3; 
trimester 3: 9.9  μg/m3) or a doubling in 3-NTp 
content (nM/mg protein). 
*p < 0.05.
Figure 2. Placental CpG-specific LEP promoter DNA methylation in association with PM2.5 exposure for 
different time windows of pregnancy (n = 361). Models were adjusted for newborn sex, maternal age, 
maternal education, maternal smoking status, gestational age, prepregnancy BMI, ethnicity, and gesta-
tional trimester-specific season. The trimester-specific PM2.5 exposure models were mutually adjusted 
for the other gestational exposure windows to estimate the independent effect of each trimester of 
exposure. Estimates are presented as absolute percentage difference in LEP promoter DNA methylation 
for a trimester-specific interquartile range increment in PM2.5 exposure (trimester 1: 8.2 μg/m3; trimester 2: 
7.5 μg/m3; trimester 3: 9.9 μg/m3). 
*p < 0.05.
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Gut 2007). Second, the placenta is a tissue 
of different cell types with the presence of 
maternal and cord blood. Because the compo-
sition of placenta samples can differ and might 
influence DNA methylation and gene expres-
sion patterns, a standardized methodological 
protocol was used for sampling each placenta 
at an almost identical position. Furthermore, 
maternal and cord blood was removed as 
much as possible, and the placental 3-NTp 
content was expressed per mg of placental 
protein. Third, we cannot exclude any residual 
confounding by other environmental factors 
or characteristics associated with the exposures 
and outcome. Despite the fact that we used 
a high-resolution receptor grid to estimate 
PM2.5 exposure, there is still a possibility for 
exposure misclassification.
Conclusions
We estimated significant negative asso-
ciations of placental LEP promoter region 
methylation with PM2.5 exposure during 
the second gestational trimester, and with 
placental 3-NTp, a marker of oxidative/nitro-
sative stress, at birth. The associated CpG 
methylation sites are flanking a nucleotide 
sequence with a regulatory function (Marchi 
et al. 2011). Additional research is needed to 
confirm our findings in other study popula-
tions and evaluate the potential impact of 
placenta LEP methylation on health during 
the neonatal period and later in life.
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